STRO - Sutro Biopharma - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

STRO is currently covered by 5 analysts with an average price target of $14.12. This is a potential upside of $10.35 (274.54%) from yesterday's end of day stock price of $3.77.

Sutro Biopharma's activity chart (see below) currently has 26 price targets and 38 ratings on display. The stock rating distribution of STRO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 31.51% with an average time for these price targets to be met of 225.29 days.

Highest price target for STRO is $17, Lowest price target is $8, average price target is $14.12.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 26-Mar-2024. First documented stock forecast 22-Oct-2018.

Currently out of the existing stock ratings of STRO, 22 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

8

$4.23 (112.20%)

12

28 days ago

2/8 (25%)

$3.82 (91.39%)

708

Buy

17

$13.23 (350.93%)

17

28 days ago

1/9 (11.11%)

$12.82 (306.70%)

24

Buy

12

$8.23 (218.30%)

16

28 days ago

0/6 (0%)

$7.82 (187.08%)

Buy

12

$8.23 (218.30%)

18

5 months 8 days ago

4/9 (44.44%)

$9.54 (387.80%)

402

Buy

25

$21.23 (563.13%)

21

1 years 3 months 10 days ago

2/5 (40%)

$17.13 (217.66%)

172

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is STRO (Sutro Biopharma) average time for price targets to be met?

On average it took 225.29 days on average for the stock forecasts to be realized with a an average price target met ratio 31.51

Which analyst has the current highest performing score on STRO (Sutro Biopharma) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on STRO (Sutro Biopharma) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on STRO (Sutro Biopharma)?

Edward Tenthoff works at PIPER SANDLER and has 7 price targets and 6 ratings on STRO

Which analyst is the currently most bullish on STRO (Sutro Biopharma)?

Zhiqiang Shu with highest potential upside - $26.81

Which analyst is the currently most reserved on STRO (Sutro Biopharma)?

David Nierengarten with lowest potential downside - $4.23

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?